Home » SRT-015 prevents acute liver injury in preclinical tests

To read the full story, subscribe or sign in.

Gastrointestinal

SRT-015 prevents acute liver injury in preclinical tests

Dec. 3, 2024

Genfit SA and its collaborators have described the preclinical efficacy of SRT-015, a liver-selective ASK1 inhibitor in models of liver failure.

BioWorld Science Conferences American Association for the Study of Liver Diseases Gastrointestinal